Patents by Inventor Jennifer Pan

Jennifer Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions having improved storage stability
    Patent number: 11969469
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: April 30, 2024
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • EVENT IDENTIFICATION THROUGH ANALYSIS OF SOCIAL-MEDIA POSTINGS
    Publication number: 20170300582
    Abstract: In various embodiments, documents such as social-media postings are analyzed to identify volume bursts, and the bursts are analyzed to compute probability metrics associated with events or types of events.
    Type: Application
    Filed: October 5, 2015
    Publication date: October 19, 2017
    Inventors: Gary KING, Jennifer PAN, Margaret E. ROBERTS
  • Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
    Patent number: 9265764
    Abstract: Aspects of this invention are related, at least in part, to the use of chemical compounds able to inhibit GSK-3 and/or to stabilize ?-catenin and formulations thereof. Some aspects of this invention relate to compositions comprising such compounds. Some aspects of the invention provide methods of using such compounds and/or compositions in the treatment of subjects having a neurological disease and/or psychiatric disorder. Some aspects of this invention provide methods of using ruboxistaurin, enzastaurin, sunitinib, midostaurin, lestaurtinib, 7-hydroxystaurosporine, and/or Chir99021 in the treatment of subjects having a neurological disease and/or psychiatric disorder. In some embodiments, compounds are administered in combination with Lithium.
    Type: Grant
    Filed: February 27, 2010
    Date of Patent: February 23, 2016
    Assignees: Massachusetts Institute of Technology, The General Hospital Corporation
    Inventors: Stephen J. Haggarty, Daniel Fass, Jennifer Pan, Josh Ketterman, Edward Holson, Tracey Lynn Petryshen, Michael C. Lewis
  • Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
    Publication number: 20110008468
    Abstract: Aspects of this invention are related, at least in part, to the use of chemical compounds able to inhibit GSK-3 and/or to stabilize ?-catenin and formulations thereof. Some aspects of this invention relate to compositions comprising such compounds. Some aspects of the invention provide methods of using such compounds and/or compositions in the treatment of subjects having a neurological disease and/or psychiatric disorder. Some aspects of this invention provide methods of using ruboxistaurin, enzastaurin, sunitinib, midostaurin, lestaurtinib, 7-hydroxystaurosporine, and/or Chir99021 in the treatment of subjects having a neurological disease and/or psychiatric disorder. In some embodiments, compounds are administered in combination with Lithium.
    Type: Application
    Filed: February 27, 2010
    Publication date: January 13, 2011
    Inventors: Stephen J. Haggarty, Daniel Fass, Jennifer Pan, Josh Ketterman, Edward Holson, Tracey Lynn Petryshen, Michael C. Lewis
  • Display screen with graphical user interface
    Patent number: D733174
    Type: Grant
    Filed: May 14, 2013
    Date of Patent: June 30, 2015
    Assignee: Microsoft Corporation
    Inventors: Gaurang Prajapati, Jennifer Pan
  • Display screen with graphical user interface
    Patent number: D733732
    Type: Grant
    Filed: May 14, 2013
    Date of Patent: July 7, 2015
    Assignee: Microsoft Corporation
    Inventors: Gaurang Prajapati, Jennifer Pan